⌕
Atricure · ATRC · Nasdaq
Tenet 52 · Mixed
Compare
$55.02−0.52%At closeTenet 52 · Mixed
$55.02−0.29 (−0.52%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Atricure (ATRC) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

The percentage on each card is ATRC's move today, from the quote feed. It is the same figure on every headline, not the move on that headline's own date.

● Business WireNov 17, 2026 · 08:00 ETCOMPANY'S OWN WORDS
AtriCure to Participate in the Piper Sandler 38th Annual Healthcare Conference

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain manage…

ATRC −0.5% todayRead at source ↗
● Seeking AlphaNov 9, 2026 · 14:01 ET
AtriCure, Inc. (ATRC) Presents at 2026 UBS Global Healthcare Conference Transcript

AtriCure, Inc. ( ATRC ) 2026 UBS Global Healthcare Conference November 9, 2026 11:00 AM EST Company Participants Angela Wirick - Chief Financial Officer Conference Call Participants Patrick Andrew Wood - UBS Investment B…

ATRC −0.5% todayRead at source ↗
● Seeking AlphaNov 8, 2026 · 00:16 ET
AtriCure: A New Quality Metric Could Put A Clip In Nearly Every Sternotomy

AtriCure is shifting from targeting AF patients to all open-heart surgery patients, aiming for broader adoption as a preventive standard of care. Upcoming catalysts include the STS quality metric rollout in 2027, BoxX-No…

ATRC −0.5% todayRead at source ↗
● BenzingaNov 4, 2026 · 05:36 ET
AtriCure Analysts Boost Their Forecasts After Better-Than-Expected Q3 Results

AtriCure, Inc. (NASDAQ:ATRC) on Tuesday posted upbeat results for the third quarter.…

ATRC −0.5% todayRead at source ↗
● Seeking AlphaNov 4, 2026 · 02:15 ET
AtriCure, Inc. (ATRC) Q3 2026 Earnings Call Transcript

AtriCure, Inc. ( ATRC ) Q3 2026 Earnings Call November 3, 2026 4:30 PM EST Company Participants Michael H. Carrel - CEO, President & Director Angela Wirick - Chief Financial Officer Conference Call Participants Marissa B…

ATRC −0.5% todayRead at source ↗
● MarketBeatNov 3, 2026 · 19:15 ET
What AtriCure (ATRC) Said on Its Q3 Earnings Call

AtriCure NASDAQ: ATRC reported third-quarter 2026 revenue of $154.5 million, up 15% from a year earlier, as growth in its U.S. open ablation, appendage management and pain management businesses helped lift profitability.…

ATRC −0.5% todayRead at source ↗
● Zacks Investment ResearchNov 3, 2026 · 18:31 ET
Compared to Estimates, AtriCure (ATRC) Q3 Earnings: A Look at Key Metrics

The headline numbers for AtriCure (ATRC) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-…

ATRC −0.5% todayRead at source ↗
● Zacks Investment ResearchNov 3, 2026 · 18:10 ET
AtriCure (ATRC) Beats Q3 Earnings and Revenue Estimates

AtriCure (ATRC) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to a loss of $0.01 per share a year ago.…

ATRC −0.5% todayRead at source ↗
● Business WireNov 3, 2026 · 16:01 ETCOMPANY'S OWN WORDS
AtriCure Reports Third Quarter 2026 Financial Results

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain managem…

ATRC −0.5% todayRead at source ↗
● Seeking AlphaOct 28, 2026 · 11:15 ET
Riverwater Small Cap Strategy Q3 2026 Portfolio Update

During the third quarter of 2026, the Small Cap strategy slightly underperformed its benchmark, the Russell 2000 Index, in a period in which small cap stocks broadly declined. Top contributors include AtriCure and Red Vi…

ATRC −0.5% todayRead at source ↗
● Business WireOct 13, 2026 · 08:00 ETCOMPANY'S OWN WORDS
AtriCure to Announce Third Quarter 2026 Financial Results

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain manage…

ATRC −0.5% todayRead at source ↗
● Defense WorldSep 25, 2026 · 04:21 ET
AtriCure (NASDAQ:ATRC) Reaches New 12-Month High – Here’s What Happened

AtriCure, Inc. (NASDAQ: ATRC - Get Free Report) shares reached a new 52-week high during trading on Wednesday. The company traded as high as $60.99 and last traded at $60.9210, with a volume of 76652 shares traded. The s…

ATRC −0.5% todayRead at source ↗
● Zacks Investment ResearchSep 14, 2026 · 10:41 ET
Is AtriCure (ATRC) Stock Outpacing Its Medical Peers This Year?

Here is how AtriCure (ATRC) and Aveanna Healthcare (AVAH) have performed compared to their sector so far this year.…

ATRC −0.5% todayRead at source ↗
● The Motley FoolSep 12, 2026 · 19:45 ET
AtriCure CTO Sells 3,657 Shares

The transaction was valued at $201,000. The sale represented 2% of the insider's direct equity holdings prior to the transaction.…

ATRC −0.5% todayRead at source ↗
● Zacks Investment ResearchSep 10, 2026 · 11:41 ET
Do Options Traders Know Something About AtriCure Stock We Don't?

Investors need to pay close attention to ATRC stock based on the movements in the options market lately.…

ATRC −0.5% todayRead at source ↗
● Zacks Investment ResearchSep 9, 2026 · 16:56 ET
AtriCure, Inc. (ATRC) Hit a 52 Week High, Can the Run Continue?

AtriCure (ATRC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.…

ATRC −0.5% todayRead at source ↗
● Zacks Investment ResearchAug 27, 2026 · 10:40 ET
Is AtriCure (ATRC) Outperforming Other Medical Stocks This Year?

Here is how AtriCure (ATRC) and Aveanna Healthcare (AVAH) have performed compared to their sector so far this year.…

ATRC −0.5% todayRead at source ↗
● Business WireAug 25, 2026 · 08:00 ETCOMPANY'S OWN WORDS
AtriCure to Participate in the 2026 Wells Fargo Health Care Conference

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain manage…

ATRC −0.5% todayRead at source ↗
● Seeking AlphaAug 21, 2026 · 08:30 ET
AtriCure: Promising Cardiovascular Surgical Platform

AtriCure is building a broader surgical platform across appendage management, ablation, and postoperative pain care. They have AtriClip, EnCompass, and cryoSPHERE. These products give them a diversified revenue base. How…

ATRC −0.5% todayRead at source ↗

Kept in their own lane. A press release is the company talking, not reporting.

No upcoming events in the feeds.

NVDA36−0.4%
DLB3−3.8%
EG3−2.0%

Article counts from the last market-wide feed page, across every symbol we track and not just ATRC · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.